BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21643682)

  • 1. Usefulness of intraoperative laser Doppler flowmetry and thermography to predict a risk of postoperative hyperperfusion after superficial temporal artery-middle cerebral artery bypass for moyamoya disease.
    Kawamata T; Kawashima A; Yamaguchi K; Hori T; Okada Y
    Neurosurg Rev; 2011 Jul; 34(3):355-62; discussion 362. PubMed ID: 21643682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser Doppler flowmeter study on regional cerebral blood flow in early stage after standard superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease.
    Gesang DZ; Zhang D; Zhao JZ; Wang S; Zhao YL; Wang R; Sun JJ; Meng Z
    Chin Med J (Engl); 2009 Oct; 122(20):2412-8. PubMed ID: 20079151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease.
    Iwaki K; Takagishi S; Arimura K; Murata M; Chiba T; Nishimura A; Ren N; Iihara K
    Cerebrovasc Dis; 2021; 50(2):208-215. PubMed ID: 33596563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Nakagawa A; Fujimura M; Arafune T; Sakuma I; Tominaga T
    J Neurosurg; 2009 Dec; 111(6):1158-64. PubMed ID: 19425891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studying change of regional cerebral blood flow after superficial temporal artery-middle cerebral artery anastomosis during acute stage in patients with Moyamoya disease].
    Gesang D; Zhao JZ; Zhang D; Wang S; Zhao YL; Wang R
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2046-9. PubMed ID: 23253806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
    Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
    Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative infrared brain surface blood flow monitoring during superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: clinical implication of the gradation value in postoperative clinical course--a case report.
    Nakagawa A; Fujimura M; Arafune T; Suzuki H; Sakuma I; Tominaga T
    Acta Neurochir Suppl; 2008; 102():159-63. PubMed ID: 19388309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.
    Sato K; Yamada M; Kuroda H; Yamamoto D; Asano Y; Inoue Y; Fujii K; Kumabe T
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1244-8. PubMed ID: 26939637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative platelet count may predict postoperative symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in moyamoya patients.
    Jo WY; Oh H; Kim H; Yoon HK; Lee HC; Cho WS; Kim JE; Park HP
    Clin Neurol Neurosurg; 2020 Dec; 199():106260. PubMed ID: 33031987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flow self-regulating superficial temporal artery-middle cerebral artery bypass based on side-to-side anastomosis for adult patients with moyamoya disease.
    Zhang J; Yu J; Xin C; Fujimura M; Lau TY; Hu M; Tian X; Luo M; Tao T; Li L; Wang C; Wei W; Li X; Chen J
    J Neurosurg; 2023 May; 138(5):1347-1356. PubMed ID: 36461841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: A retrospective observational study.
    Seo H; Ryu HG; Son JD; Kim JS; Ha EJ; Kim JE; Park HP
    Medicine (Baltimore); 2016 Dec; 95(52):e5712. PubMed ID: 28033272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative middle cerebral artery pressure measurements during superficial temporal artery to middle cerebral artery bypass procedures in patients with cerebral atherosclerotic disease.
    Matano F; Murai Y; Tanikawa R; Kamiyama H; Tateyama K; Tamaki T; Mizunari T; Mizumura S; Kobayashi S; Teramoto A; Morita A
    J Neurosurg; 2016 Dec; 125(6):1367-1373. PubMed ID: 26943849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Occurrence of Hemorrhagic Cerebral Hyperperfusion Syndrome Using Regional Cerebral Blood Flow After Direct Bypass Surgery in Patients with Moyamoya Disease.
    Ishikawa T; Yamaguchi K; Kawashima A; Funatsu T; Eguchi S; Matsuoka G; Nomura S; Kawamata T
    World Neurosurg; 2018 Nov; 119():e750-e756. PubMed ID: 30092464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.